Skip to main content
OpenTrials

Clinical trial condition

Adrenocortical Carcinoma

Explore clinical trials studying Adrenocortical Carcinoma. Study availability and eligibility vary by location and protocol.

40 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Adrenocortical Carcinoma trial results

Recruiting

Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma

NCT06066333

Conditions
ACC, Adenocarcinoma, Adrenal Cortex Diseases, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack Commack, New York, United States
View Trial Details
Recruiting

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

NCT06333314

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +28 more
Locations
  • Institut de Cancérologie de l'Ouest Angers, France
  • Institut du Cancer Avignon-Provence Avignon, France
  • CHU Jean Minjoz Besançon, France
  • CHU Morvan Brest, France
View all 22 locations
View Trial Details
Recruiting

Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.

NCT05563467

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations
  • Maria Sklodowska-Curie National Research Institute of Oncology Gliwice, Silesian Voivodeship, Poland
  • Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie Cracow, Poland
  • Uniwersytecki Szpital Kliniczny W Poznaniu Poznan, Poland
  • Medical University Of Warsaw Warsaw, Poland
View Trial Details

Related conditions